Search Results

1437P Tislelizumab (TIS) + chemotherapy (CT) vs placebo (PBO) + CT in HER2-negative advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GC/GEJC): RATIONALE-305 study minimum 3-year survival follow-up.

• Authors : Cruz-Correa, M.¹ (AUTHOR); Oh, D-Y.² (AUTHOR); Kato, K.³ (AUTHOR)

Subjects: *ADENOCARCINOMA; *PLACEBOS; *CANCER chemotherapy

• Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS893-S894. 2p.

Record details

1423P Zanidatamab + chemotherapy for first-line (1L) treatment of HER2+ advanced or metastatic gastro-oesophageal adenocarcinoma (mGEA): New and updated data from a phase II trial.

• Authors : Elimova, E.¹ (AUTHOR); Ajani, J.A.² (AUTHOR); Burris, H.A.³ (AUTHOR)

Subjects: *ADENOCARCINOMA; *CANCER chemotherapy; *METASTASIS

• Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS887-S888. 2p.

Record details

739P Comparison of breast and gastric HER2 immunohistochemistry (IHC) scoring criteria in the assessment of endometrial endometrioid adenocarcinoma (EEA).

• Authors : Grither, W.R.¹ (AUTHOR); Evans, M.G.² (AUTHOR); Ali-Fehmi, R.³ (AUTHOR)

Subjects: *IMMUNOHISTOCHEMISTRY; *ADENOCARCINOMA

• Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS562-S563. 2p.

Record details

Transcription factor EHF interacting with coactivator AJUBA aggravates malignancy and acts as a therapeutic target for gastroesophageal adenocarcinoma.

• Authors : Peng, Li; Jiang, Yanyi; Chen, Hengxing

Subjects: TRANSCRIPTION factors; GENE regulatory networks; ADENOCARCINOMA

• Source: Acta Pharmaceutica Sinica B; May2024, Vol. 14 Issue 5, p2119-2136, 18p

Record details

416P Evolutionary and immune microenvironment dynamics determine response to neoadjuvant treatment of oesophageal adenocarcinoma.

• Authors : Barroux, M.¹ (AUTHOR); Househam, J.² (AUTHOR); Lakatos, E.³ (AUTHOR)

Subjects: *NEOADJUVANT chemotherapy; *ADENOCARCINOMA

• Source: Annals of Oncology. 2024 Supplement 1, Vol. 35, pS168-S169. 2p.

Record details

445P Survival among patients cured from gastric adenocarcinoma compared to the background population.

• Authors : Leijonmarck, W.¹ (AUTHOR)

Subjects: *ADENOCARCINOMA

• Source: Annals of Oncology. 2024 Supplement 1, Vol. 35, pS178-S179. 2p.

Record details

4MO Is it time for a new staging system for colon adenocarcinoma (CA)?

• Authors : Dasari, N.A.¹ (AUTHOR); Jurdi, A.² (AUTHOR); Nakamura, Y.³ (AUTHOR)

Subjects: *COLON (Anatomy); *ADENOCARCINOMA

• Source: Annals of Oncology. 2024 Supplement 1, Vol. 35, pS3-S4. 2p.

Record details

Quantification of Intratumoral Heterogeneity: Distinguishing Histological Subtypes in Clinical T1 Stage Lung Adenocarcinoma Presenting as Pure Ground-Glass Nodules on Computed Tomography.

• Authors : Zhang, Jian; Sha, Jinlu; Liu, Wen

• Source: Academic Radiology; Oct2024, Vol. 31 Issue 10, p4244-4255, 12p

Record details

Gastric adenocarcinoma with carcinomatosis and degenerative joint disease of the xiphisternum in a Bactrian camel (Camelus bactrianus).

• Authors : Van de Weyer, Yannick; Bentley, Charlotte; Orlowska, Anna

Subjects: OSTEOARTHRITIS; PERITONEAL cancer; CAMELS

• Source: Journal of Comparative Pathology; Oct2024, Vol. 214, p7-11, 5p

Record details

Spread Through Air Spaces in Residual Tumor Classification for Clinical IA Lung Adenocarcinoma.

• Authors : Si, Haojie; Xu, Long; Zhao, Yue

• Source: Annals of Thoracic Surgery; Oct2024, Vol. 118 Issue 4, p825-833, 9p

Record details